Home » Topics » Conferences

Conferences
RSS

SKB discovers first selective human 5-HT1B receptor ligand

June 27, 1997

Novel anxiolytic and antidepressant buspirone analogue characterized

June 27, 1997

Potential new antidiabetic and antiobesity agent from Dainippon

June 26, 1997

Abbott selects new motilide as candidate for GI motility disorders

June 26, 1997

Naratriptan highlighted at headache congress; introduced in U.K.

June 26, 1997

Pharmacological profile of TBC-11251, a selective, orally active ETA antagonist

June 25, 1997

SR-49059: a selective vascular V1 receptor antagonist

June 25, 1997

Pharmacokinetics and antihypertensive efficacy of the new AII antagonist CS-866

June 25, 1997

LU-135252 evaluated in models of acute renal failure and hypertension

June 25, 1997

Preclinical and preliminary clinical results reported for alniditan

June 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...